Wall Street reopens after Labor Day, and tonight is the first live test of two big stories: the AI power buildout and a surge in oil.
US stock markets reopen tonight after closing Monday for Labor Day. That makes this session the first direct reaction to everything that piled up over the long weekend.
Two themes dominate. First, spending on AI data centers keeps flowing. Second, worries about Fed rate hikes and oil near US$100 have Dow futures slipping.
For anyone watching US stocks, tonight is about balancing AI momentum against rising macro risk.
Tonight's Watchlist
| Stock | Movement | What to Watch |
|---|
| NVDA | AI catalyst in focus | Nvidia-backed Firmus signed a deal with OpenAI for Malaysia data-center capacity, underscoring AI chip demand. |
| FLEX | AI power play | Flex is making a US$4.4 billion bet on AI power infrastructure. |
| BE | S&P 500 debut | Bloom Energy joined the S&P 500 as its AI-linked rally continues. |
| GILD | Drug approval catalyst | New HIV drug Bixlenvo opens a fresh growth path for Gilead. |
| LLY | Obesity-drug spotlight | Mounjaro's new heart benefit could unlock Lilly's next growth phase. |
Pre-market percentage moves are filled closer to publish (around 17:00 WIB).
Tonight's Catalysts
The AI data-center power buildout keeps accelerating
AI momentum has not cooled. Nvidia (NVDA)-backed Firmus just signed a deal with OpenAI for data-center capacity in Malaysia. On the power side, Flex (FLEX) announced a US$4.4 billion bet on AI power, and Bloom Energy (BE) officially joined the S&P 500 on the back of its AI-linked rally.
The Fed, oil, and gold turn up the pressure
On the macro side, Dow futures slipped amid Fed rate-hike bets and a jump in oil. Crude is approaching US$100 as tensions around the Strait of Hormuz build, while gold edged higher as traders hedge. Rate-sensitive tech faces real pressure tonight.
A wave of biotech approvals
Biotech is busy with catalysts. Gilead (GILD) won approval for new HIV drug Bixlenvo, opening a new growth market. Eli Lilly (LLY) is highlighting a new heart benefit for Mounjaro amid its fierce obesity-drug race with Novo Nordisk.
Pre-Market Pulse 📊
Heading into the open, US futures lean cautious. Dow futures are reported lower on the mix of rate worries and higher oil. Beyond the watchlist, memory names could catch a bid after SK Hynix strength in Asia.
Macro Note 📝
Oil near US$100 and a firmer gold price suggest investors are reaching for hedges. Strait of Hormuz tension is the variable to watch through the session.
Conclusion
Tonight is a real test of whether AI spending momentum is strong enough to offset pressure from rates and oil. These two stories will set the tone for the post-holiday reopen.
If you trade actively, watch the early reaction in AI names versus energy. What stocks are you watching tonight?
Build your watchlist and start investing from US$1 with Gotrade. Check Watchlist on Gotrade.